智通港股股东权益披露|11月7日

智通财经网· 2025-11-07 08:08
智通财经APP获悉,药师帮(09885)、百心安-B(02185)于2025年11月7日进行了最新股东权益披露。 | 股票名称 | 机构名称 | 性质 | 变动前持股 | 变动后持股 | 持股比 | | --- | --- | --- | --- | --- | --- | | 药师帮(09885) | 陈飞 | 好仓 | 830.00 万股 | 850.00 万股 | 1.25%(最新) 1.22%(前次) | | 百心安-B(02185) | Wang Philip Li | 好仓 | 8483.77 万股 | 8484.77 万股 | 35.99%(最新) 35.99%(前次) | 备注:持股数变动有可能因供股、合股、拆股等情况引起,请注意对照实际情况进行辨别。 ...
特斯拉:每台机器人成本将控制在2万美元以内
新浪财经· 2025-11-07 08:08
特斯拉AI:特斯拉(TSLA.O)人形机器人的试生产产线已经在弗里蒙特工厂开始运行,规模更大的第三 代人形机器人的生产线将于2026年建成投产,机器人规模化生产后,预计每台成本将控制在2万美元以 内。 ...
Carmaker Stellantis pulls plug on supply deal with Australia's Alliance Nickel
Reuters· 2025-11-07 08:08
Australia's Alliance Nickel said on Friday carmaker Stellantis will terminate their supply deal for battery-grade nickel and cobalt from the NiWest project, effective December 3, citing missed milesto... ...
毒株变了,占比超90%,莫把这种流感当感冒治!
新京报· 2025-11-07 08:07
近期,随着全国各地气温下降,流感病毒进入活跃期。 根据中国疾控中心发布的2025年第43周流感监测周报,我国南方省份流感活动上升,北方省份流感活动呈低水平。 同时最新监测结果显示,甲型H3N2毒株占流感病例的90%以上,而去年主要是甲型H1N1毒株。首都医科大学附属北京朝阳医院感染和临床微生物科李冉 介绍,普通人对甲型H3N2毒株没有抵抗力。 甲流感染与感冒症状相似,但并不完全相同,与普通感冒相比,甲流H3N2感染后,症状更重,而且时间也更久。 专家介绍,H3N2传播性较强,对于老年人、备孕人群、孕妇和小孩 ,积极接种疫苗是最佳防控方式。日常还需做好戴口罩、少去人群聚集场所、保持个 人卫生,关注气温变化,降低感染风险。 所有呼吸道病原体中,流感上升最快 . 呼吸道样本病原体核酸检测阳性率(%) 病原体 门急诊流感样病例( 第43周 ■ 较上周) 12.8 1.8 量病毒 流感病毒 10.5 4.4 肠道病毒 1.5 OP 呼吸道合胞病毒 7 1.1 副流感病毒 3.1 0.1 普通冠状病毒 1.7 -0.9 新型冠状病毒 1.5 -0.2 博卡病毒 1.4 -0.6 腺病毒 1 -0.4 肺炎支原体 0.4 ...
Diodes (DIOD) Q3 Earnings and Revenues Lag Estimates
ZACKS· 2025-11-07 08:06
Diodes (DIOD) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.43 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -2.63%. A quarter ago, it was expected that this semiconductor components maker would post earnings of $0.24 per share when it actually produced earnings of $0.32, delivering a surprise of +33.33%.Over the last four quarter ...
American Healthcare REIT (AHR) Tops Q3 FFO and Revenue Estimates
ZACKS· 2025-11-07 08:06
American Healthcare REIT (AHR) came out with quarterly funds from operations (FFO) of $0.44 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to FFO of $0.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of +4.76%. A quarter ago, it was expected that this real estate investment trust would post FFO of $0.4 per share when it actually produced FFO of $0.42, delivering a surprise of +5%.Over the last fou ...
QuinStreet (QNST) Q1 Earnings Meet Estimates
ZACKS· 2025-11-07 08:06
QuinStreet (QNST) came out with quarterly earnings of $0.22 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.22 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this online marketing services company would post earnings of $0.26 per share when it actually produced earnings of $0.25, delivering a surprise of -3.85%.Over the last four quarters, the company has not been able to surpass consensus EPS estimates.Qui ...
Sunrun (RUN) Q3 Earnings and Revenues Top Estimates
ZACKS· 2025-11-07 08:06
Sunrun (RUN) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to a loss of $0.37 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +500.00%. A quarter ago, it was expected that this solar energy products distributor would post a loss of $0.18 per share when it actually produced earnings of $1.07, delivering a surprise of +694.44%.Over the last four quarte ...
IDEAYA Biosciences, Inc. (IDYA) Presents at Citi's 2025 SMID Cap Biopharma Call Series Transcript
Seeking Alpha· 2025-11-07 08:06
PresentationYigal NochomovitzCitigroup Inc., Research Division All right. Great. Hopefully, everyone is connected. Well, I'm Yigal Nochomovitz, biotech analyst here at Citi in New York City. It is my pleasure to introduce the next iteration in our virtual C-suite fireside chat series with Yujiro Hata, who, of course, needs no introduction, the CEO of IDEAYA. If you guys have questions for Yujiro during the course of the conversation, please e-mail me, yigal.nochomovitz@citi.com, and I will hopefully see th ...
Uzbekistan Airways Finalizes Order for Eight More Boeing 787 Dreamliners
Prnewswire· 2025-11-07 08:06
Accessibility StatementSkip Navigation WASHINGTON, Nov. 6, 2025 /PRNewswire/ -- Boeing [NYSE: BA] and Uzbekistan Airways announced today the conversion of options into a firm order for eight 787 Dreamliners, bringing the flag carrier's total order book to 22 of the versatile widebody jets. Continue Reading Pictured: Paul Righi, Boeing vice president of Sales and Marketing for Eurasia and India; Howard Lutnick, U.S. Secretary of Commerce; Laziz Kudratov, Minister of Investment, Industry and Trade of the Re ...